Published in The Lancet · View the paper (DOI)
A 14-year study found that annual screening with a blood test utilizing the Risk of Ovarian Cancer Algorithm (ROCA) significantly reduced mortality from ovarian cancer, particularly in women without evidence of cancer at study entry. The results showed a 20% reduction in risk of dying from ovarian cancer.
Coverage from 2 institutions